liraglutide
Showing 1 - 25 of 281
Polycystic Ovary Trial in Bani Suwayf (liraglutide, Metformin)
Not yet recruiting
- Polycystic Ovary
- liraglutide
- Metformin
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university Hospital
Jul 28, 2023
Obesity, Childhood, Neural Development Trial in New Haven (Liraglutide)
Completed
- Obesity, Childhood
- Neural Development
- Liraglutide
-
New Haven, ConnecticutYale University
Dec 5, 2022
Parkinson Disease Trial in Los Angeles (Liraglutide, Placebo)
Completed
- Parkinson Disease
- Liraglutide
- Placebo
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Oct 27, 2022
Growth Hormone Deficiency, Healthy Trial in New York (growth hormone and lirglutide, growth hormone, liraglutide)
Not yet recruiting
- Growth Hormone Deficiency
- Healthy
- growth hormone and lirglutide
- +3 more
-
New York, New YorkNeuroendocrine Unit and Pituitary Center, Columbia University Ir
Dec 27, 2022
Obesity, Status Post Sleeve Gastrectomy Trial run by the NICHD (Liraglutide)
Recruiting
- Obesity
- Status Post Sleeve Gastrectomy
- Liraglutide
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 16, 2022
Diabetes, Type 1 Trial in Monterrey (Liraglutide)
Recruiting
- Diabetes Mellitus, Type 1
- Liraglutide
-
Monterrey, Nuevo León, MexicoCentro Médico Nacional del Noreste Hospital de Especialidades UM
Jul 19, 2022
Obesity Trial in Rochester (Liraglutide, Placebo)
Completed
- Obesity
- Liraglutide
- Placebo
-
Rochester, MinnesotaMayo Clinic in Rochester
May 27, 2022
Obese, Overweight Trial in Shanghai (Liraglutide, Placebo)
Active, not recruiting
- Obese
- Overweight
- Liraglutide
- Placebo
-
Shanghai, ChinaZhongshan Hosital, Fudan University
Apr 16, 2022
Type 2 Diabetes Trial in Chongqing (Liraglutide, Oral antidiabetic drugs: Metformin, Sulfonylureas (2nd generation),
Completed
- Type 2 Diabetes Mellitus
- Liraglutide
- Oral antidiabetic drugs: Metformin, Sulfonylureas (2nd generation), Thiazolidinediones, α-Glucosidase inhibitors, and Glinides
-
Chongqing, Chongqing, ChinaThe third hospital affiliated to the Third Military Medical Univ
Apr 30, 2022
Type 2 Diabetes Trial in Helsinki (Liraglutide, Placebo)
Completed
- Type 2 Diabetes
- Liraglutide
- Placebo
-
Helsinki, FinlandHelsinki University Central Hospital
Apr 11, 2022
Type 1 Diabetes Trial in Buffalo (Liraglutide)
Active, not recruiting
- Type 1 Diabetes
- Liraglutide
-
Buffalo, New YorkUBMD Pediatrics, Division of Pediatric Endocrinology
Mar 7, 2022
Type 2 Diabetes Treated With Insulin, Obesity, Adolescent Obesity Trial in Lahore (Dulaglutide, Liraglutide)
Completed
- Type 2 Diabetes Treated With Insulin
- +2 more
- Dulaglutide
- Liraglutide
-
Lahore, Punjab, PakistanZainab Khan
Mar 11, 2022
Bipolar Disorder, Obesity Trial in Mason (LIRAGLUTIDE, Placebo)
Active, not recruiting
- Bipolar Disorder
- Obesity
- LIRAGLUTIDE
- Placebo
-
Mason, OhioLindner Center of HOPE
May 24, 2022
Diabete Type 2 Trial (Liraglutide, Placebo)
Not yet recruiting
- Diabete Type 2
- Liraglutide
- Placebo
- (no location specified)
Feb 24, 2022
Ischemic Stroke, Transient Ischemic Attack, Type 2 Diabetes Trial in Guangzhou (Liraglutide)
Recruiting
- Ischemic Stroke
- +2 more
- Liraglutide
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Jinan University
Mar 17, 2022
Harmonizing RCT-Duplicate Emulations In A Real World Replication
Completed
- Type 2 Diabetes Mellitus
- Canagliflozin
- +4 more
-
Gothenburg, SwedenResearch Site
Oct 23, 2023
Type2 Diabetes Trial in Charlottesville (Exercise, Liraglutide)
Recruiting
- Type2 Diabetes
- Exercise
- Liraglutide
-
Charlottesville, VirginiaUniversity of Virginia
Mar 7, 2022
Healthy Trial in Singapore (LY3537021, Liraglutide, Placebo)
Active, not recruiting
- Healthy
- LY3537021
- +2 more
-
Singapore, SingaporeLilly Centre for Clinical Pharmacology
Nov 22, 2022
Diabetes, Type 2, Hemodialysis, Obese Trial in Paris, Saint-Ouen (Liraglutide)
Recruiting
- Diabetes Mellitus, Type 2
- +2 more
- Liraglutide
-
Paris, Groupe Hospitalier Paris Saint-Joseph, France
- +3 more
Mar 30, 2022
Overweight, Obesity Trial in United States (Semaglutide, Placebo (semaglutide), Liraglutide)
Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- liraglutide
- placebo
-
Santa Monica, California
- +31 more
Nov 18, 2022
Obesity, Visceral, Cardiovascular Diseases, Fat Disorder Trial in Dallas (Liraglutide, Placebo)
Completed
- Obesity, Visceral
- +2 more
- Liraglutide
- Placebo
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Oct 20, 2021
Obesity Trial in Loma Linda (Semaglutide, Orlistat, Phentermine/Topiramate)
Recruiting
- Obesity
- Semaglutide
- +4 more
-
Loma Linda, CaliforniaNovo Nordisk Investigational Site
Jan 24, 2023
Type 2 Diabetes, Mild Cognitive Impairment Trial in Nanjing (Liraglutide, Empagliflozin, Linagliptin)
Recruiting
- Type 2 Diabetes Mellitus
- Mild Cognitive Impairment
- Liraglutide
- +2 more
-
Nanjing, Jiangsu, China
- +1 more
Mar 28, 2022